Hallux Valgus – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
Hallux valgus (HV), commonly known as a bunion, is a prevalent deformity affecting the forefoot. HV is characterized by lateral deviation of the proximal phalanx and medial deviation of the first metatarsal head, resulting from the adduction of the first metatarsus, known as metatarsus primus varus. The exact cause of HV is not fully understood, but it is likely the result of multiple contributing factors. These factors include genetics, a shortened first metatarsal, dorsiflexion (upward bending) of the first metatarsal, flexible or rigid varus deformity of the forefoot, flexible or rigid pes planovalgus (flatfoot), gastrocnemius equinus (tight calf muscles), abnormal foot mechanics, and joint hypermobility. HV deformity is commonly observed in individuals with connective tissue disorders such as Marfan syndrome, Ehlers-Danlos syndrome, and those with Down syndrome. The pathophysiology of HV is complex, involving an imbalance between the extrinsic and intrinsic muscles of the foot, along with the involvement of ligaments. The alignment of the first metatarsal is maintained through tension created by the peroneus longus muscle laterally and the abductor hallucis muscle medially. Other conditions to consider when evaluating patients with suspected HV deformity include osteoarthrosis, Freiberg disease, hallux rigidus, Morton neuroma, turf toe, gout, and septic joint. Physical examination is typically sufficient for diagnosing hallux valgus deformity, but imaging is important to assess potential damage to the first metatarsophalangeal (MTP) joint. Treatment options for HV deformity include both non-surgical and surgical approaches. The prognosis for HV deformity is generally favorable. Complications associated with HV deformity may include bursitis (most common), hammertoe deformity of the second toe, degenerative disease of the metatarsal head, central metatarsalgia, entrapment of the medial dorsal cutaneous nerve, and synovitis of the MTP joint. HV deformity is more prevalent in women than in men.
·
The incidence of incident hallux valgus in
adults aged 50 years or older is approximately 1 in 5 over seven years, and it
is associated with age, poorer physical health, foot pain, and previous use of
constrictive footwear.
Thelansis’s “Hallux Valgus Market Outlook,
Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To
2032" covers disease overview, epidemiology, drug utilization,
prescription share analysis, competitive landscape, clinical practice,
regulatory landscape, patient share, market uptake, market forecast, and key
market insights under the potential Hallux Valgus treatment modalities options
for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and
China).
KOLs insights
of Hallux Valgus across 8 MM market from the centre of Excellence/ Public/
Private hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Hallux Valgus Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment